CRVS- Corvus Pharmaceuticals, Inc.

CRVS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Miller Richard A Md	1.19M	$14.38M	-
CFO	Lea Leiv	400.0K	-	-
Other	Jones William Benton	400.0K	-	-
Other	Arcara Jeffrey	100.0K	-	-
Dir	Chan Andrew C.	30.0K	-	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 20, 2021	Miller Richard A Md64	President And CEO	Buy	10,000	$1.93	$19,254.00	+0.8%	+79.1%	-42.4%
May 4, 2021	Miller Richard A Md64	President And CEO	Buy	35,714	$2.80	$99,999.20	New	-24.6%	-51.8%
Feb 17, 2021	Thompson Peter A.63	Director, 10% Owner	Buy	1,285,714	$3.50	$4,499,999.00	+19.0%	-	-
Feb 17, 2021	Orbimed Advisors LLC66	Director, 10% Owner	Buy	1,285,714	$3.50	$4,499,999.00	+19.0%	-	-
Feb 17, 2021	Miller Richard A Md64	President And CEO	Buy	100,000	$3.50	$350,000.00	+8.5%	-	-
Jul 8, 2020	Novo Holdings A/s58	10% Owner	Sell	1,538,062	$5.31	$8,168,546.63	-52.5%	-	-
Nov 13, 2019	Miller Richard A Md64	President And CEO	Buy	15,008	$3.00	$45,029.22	+1.3%	-	-
Aug 7, 2019	Miller Richard A Md64	President And CEO	Buy	7,500	$3.56	$26,725.00	+0.6%	-	-
Aug 6, 2019	Orbimed Advisors LLC66	Director, 10% Owner	Buy	142,656	$3.51	$500,722.56	+2.2%	-	-
Aug 6, 2019	Thompson Peter A.63	Director, 10% Owner	Buy	142,656	$3.51	$500,722.56	+2.2%	-	-